Através deste estudo, pode ser afirmado que, considerando os marcadores relacionados ao ritmo de remodelação óssea e vascularização, as doenças analisadas não se diferenciaram.
31 REFERÊNCIAS
BAGAN, J. V. et al. Osteonecrosis of the jaws by intravenous bisphosphonates and osteoradionecrosis: a comparative study. Med Oral Patol Oral Cir Bucal, Valencia, España, v. 14, n. 12, p. e616-e619, Dec. 2009. Disponível em:
<http://www.medicinaoral.com/pubmed/medoralv14_i12_p616.pdf>. Acesso em: 20 maio 2017.
BOOCOCK, C. A. et al. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst, Cary, NC, v. 87, n.
7, p. 506–516, Apr. 1995. Disponível em:
<https://www.ncbi.nlm.nih.gov/pubmed/7707437>. Acesso em: 27 nov. 2017.
BOYCE, B. F.; XING, L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys, San Diego, CA, v. 473, n. 2, p.139-146, May 2008. Disponível em:
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413418/pdf/nihms50780.pdf>.
Acesso em: 25 nov. 2017.
CARDOSO, C. L. et al. Radiographic Findings in Patients with Medication-Related Osteonecrosis of the Jaw. Int J Dent, [Cairo], v. 2017, p. 1-6, Mar. 2017. Disponível em:
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352898/pdf/IJD2017-3190301.pdf>. Acesso em: 25 nov. 2017.
CARMAGNOLA, D. et al. Histological findings on jaw osteonecrosis associated with bisphosphonates (BONJ) or with radiotherapy (ORN) in humans. Acta Odontol Scand, Abingdon, Oxford, v. 71, n. 6, p. 1410-1417, Nov. 2013. Disponível em:
<https://www.ncbi.nlm.nih.gov/pubmed/23445246>. Acesso em: 20 maio 2017.
CHEUNG, K. et al. CD31 signals confer immune privilege to the vascular
endothelium. Proc Natl Acad Sci U S A, Washington, DC, v. 112, n. 43, p.E5815–
E5824, Oct. 2015. Disponível em:
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629379/pdf/pnas.201509627.pdf>.
Acesso em: 12 maio 2017.
CHINTALGATTU, V.; NAIR, D. M.; KATWA, L. C. Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR.
J Mol Cell Cardiol, London, New York, v. 35, n. 3, p. 277–286, Mar. 2003.
Disponível em: <https://www.ncbi.nlm.nih.gov/pubmed/12676542>. Acesso em: 20 maio 2017.
DE ANTONI, C. C. et al. Medication-related osteonecrosis of the jaw,
osteoradionecrosis, and osteomyelitis: A comparative histopathological study. Braz Oral Res, São Paulo, v. 32, p. 1-7, 2018. Disponível em:
<http://www.scielo.br/pdf/bor/v32/1807-3107-bor-1807-3107bor-2018vol320023.pdf>. Acesso em: 1 set. 2018.
DELISSER, H. M. et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis.
Am J Pathol, New York, v. 151, n. 3, p. 671–677, Sept. 1997. Disponível em:
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857836/pdf/amjpathol00021-32 0033.pdf>. Acesso em: 28 nov. 2017.
FERRARA, N. et al. Heterozygous embryonic lethality induced by targeted
inactivation of the VEGF gene. Nature, Basingstoke, v. 380, n. 6573, p. 439–442, Apr. 1996. Disponível em: <https://www.ncbi.nlm.nih.gov/pubmed/8602242>. Acesso em: 27 nov. 2017.
GROSS, C. et al. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis. J Transl Med, [London], v. 15, p. 1-14, June 2017. Disponível em:
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461625/pdf/12967_2017_Article_12 30.pdf>. Acesso em: 21 maio 2017.
GUIMARÃES, E. P. et al. Clinical Management of Suppurative Osteomyelitis, Bisphosphonate-Related Osteonecrosis, and Osteoradionecrosis: Report of Three Cases and Review of the Literature. Case Rep Dent, Cairo, v. 2013, p. 1-5, 2013.
Disponível em:
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814104/pdf/CRIM.DENTISTRY201 3-402096.pdf>. Acesso em: 25 nov. 2017.
GUMINA, R. J. et al. The human PECAM1 gene maps to 17q23. Genomics, San Diego, v. 34, n. 2, p. 229-232, Jan. 1996. Disponível em:
<https://www.ncbi.nlm.nih.gov/pubmed/8661055>. Acesso em: 21 nov. 2017.
HAMMER, Ø.; HARPER, D. A. T.; RYAN, P. D. PAST: Paleontological Statistics Software Package for Education and Data Analysis. Palaeontol Electronica, [College Station, Tex.], v. 4, n. 1, p. 1-9, May 2001. Disponível em: <https://palaeo-electronica.org/2001_1/past/past.pdf>. Acesso em: 22 nov. 2017.
HANSEN, T. et al. Osteonecrosis of the jaws in patients treated with bisphosphonates – histomorphologic analysis in comparison with infected
osteoradionecrosis. J Oral Pathol Med, Oxford, UK, v. 35, n. 3, p. 155-160, Feb.
2006. Disponível em: <https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-0714.2006.00391.x>. Acesso em: 25 nov. 2017.
ILAN, N.; MADRI, J. A. PECAM-1: old friend, new partners. Curr Opin Cell Biol, London, v. 15, n. 5, p. 515–524, Oct. 2003. Disponível em:
<https://www.ncbi.nlm.nih.gov/pubmed/14519385>. Acesso em: 23 nov. 2017.
ITAKURA, J. et al. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int J Cancer, New York, NY, v. 85, n. 1, p.
27–34, Jan. 2000. Disponível em:
<https://www.ncbi.nlm.nih.gov/pubmed/10585578>. Acesso em: 27 nov. 2017.
KISHIMOTO, T. et al. Leucocyte typing VI: white cell differentiation antigens.
New York: Garland Publishing Inc., 1997.
KUMAR, V.; ABBAS, A.; ASTER, J. Robbins & Cotran Pathologic Basis of Disease. 8th ed. United States: Saunders Elsevier, 2009.
33 LERTKIATMONGKOL, P. et al. Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31). Curr Opin Hematol, Philadelphia, PA, v. 23, n. 3, p.
253-259, May 2016. Disponível em:
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986701/pdf/nihms802953.pdf>.
Acesso em: 26 nov. 2017.
LEW, D. P.; WALDVOGEL, F. A. Osteomyelitis. Lancet, London, v. 364, p. 369-379, July 2004. Disponível em: <https://bit.ly/2PMB0KZ>. Acesso em: 25 nov. 2017.
LUVIZUTO, E. R. et al. Osteocalcin immunolabeling during the alveolar healing process in ovariectomized rats treated with estrogen or raloxifene. Bone, New York, v. 46, n. 4, p. 1021-1029, Apr. 2010. Disponível em:
<https://www.ncbi.nlm.nih.gov/pubmed/20036346>. Acesso em: 23 nov. 2017.
MARX, R. E. Osteoradionecrosis: A new concept of its pathophysiology. J Oral Maxillofac Surg, [Philadelphia, PA], v. 41, n. 5, p. 283-288, 1983. Disponível em:
<https://bit.ly/2OHA9Le>. Acesso em: 25 nov. 2017.
MARX, R. E.; TURSUN, R. Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease. Int J Oral Maxillofac Surg, Copenhagen, v. 41, n. 3, p. 283-289, Mar. 2012. Disponível em:
<https://www.sciencedirect.com/science/article/pii/S0901502711015724>. Acesso em: 25 nov. 2017.
MITSIMPONAS, K. T. et al. Osteo-radio-necrosis (ORN) and bisphosphonate-related osteonecrosis of the jaws (BRONJ): the histopathological differences under the clinical similarities. Int J Clin Exp Pathol, Madison, WI, v. 7, n. 2, p.496-508, Jan.
2014. Disponível em:
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925894/pdf/ijcep0007-0496.pdf>.
Acesso em: 24 nov. 2017.
NEWMAN, P. J.; NEWMAN, D. K. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology.
Arterioscler Thromb Vasc Biol, Baltimore, Md, v. 23, n. 6, p. 953–964, June 2003.
Disponível em: <https://www.ncbi.nlm.nih.gov/pubmed/12689916>. Acesso em: 19 nov. 2018.
ODGREN, P. R. et al. Evidence that the rat osteopetrotic mutation toothless (tl) is not in the TNFSF11 (TRANCE, RANKL, ODF, OPGL) gene. Int J Dev Biol, Vizcaya, Spain, v. 45, n. 8, p. 853-859, Dec. 2001. Disponível em:
<https://www.ncbi.nlm.nih.gov/pubmed/11804028>. Acesso em: 22 nov. 2017.
PRIVRATSKY, J. R.; NEWMAN, D. K.; NEWMAN, P. J. PECAM-1: conflicts of interest in inflammation. Life Sci, Amsterdam, v. 87, n. 3-4, p. 69–82, July 2010.
Disponível em: <https://www.ncbi.nlm.nih.gov/pubmed/20541560>. Acesso em: 23 nov. 2017.
RADCLIFFE, G. (iii) Osteomyelitis – a historical and basic sciences review. Orthop Trauma, Oxford, v. 29, n. 4, p. 243-252, Aug. 2015. Disponível em:
34
<https://bit.ly/2pji62Z>. Acesso em: 25 nov. 2017.
ROBLING, A. G.; CASTILLO, A. B.; TURNER, C. H. Biomechanical and molecular regulation of bone remodeling. Annu Rev Biomed Eng, Palo Alto, Calif, v. 8, p. 455-498, 2006. Disponível em: <https://www.ncbi.nlm.nih.gov/pubmed/16834564>.
Acesso em: 22 nov. 2017.
ROCHA, G. C. M. A. et al. Radiographic evaluation of maxillofacial region in oncology patients treated with bisphosphonates. Oral Surg Oral Med Oral Pathol Oral Radiol, New York, NY, v. 114, n. 5, Suppl., p. S19-S25, Nov. 2012. Dispónível em: <https://www.ncbi.nlm.nih.gov/pubmed/23083951>. Acesso em: 23 abr. 2017.
RUGGIERO, S. L. et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg, [Philadelphia, PA], v. 72, n. 10, p. 1938-1956, Oct. 2014.
Disponível em: <https://www.ncbi.nlm.nih.gov/pubmed/25234529>. Acesso em: 25 maio 2017.
SHUSTER, A. et al. Comparison of the histopathological characteristics of
osteomyelitis, medication-related osteonecrosis of the jaw, and osteoradionecrosis.
Int J Oral Maxillofac Surg, Copenhagen, in press, 2018. Disponível em:
<https://www.ijoms.com/article/S0901-5027(18)30249-2/pdf>. Acesso em: 18 set.
2018.
STOUFFER, R. L. et al. Regulation and action of angiogenic factors in the primate ovary. Arch Med Res, New York, NY, v. 32, n. 6, p. 567-575, Nov./Dec. 2001.
Disponível em: <https://www.ncbi.nlm.nih.gov/pubmed/11750732>. Acesso em: 14 nov. 2017.
STREET, J. et al. Vascular endothelial growth factor stimulates bone repair by
promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A, Washington, DC, v. 99, n. 15, p. 9656-9661, July 2002. Disponível em:
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC124965/pdf/pq1502009656.pdf>.
Acesso em: 24 nov. 2017.
SUTO, K. et al. Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J Biol Chem, Baltimore, MD, v. 280, n. 3, p. 2126–2131, Jan. 2005. Disponível em:
<https://www.ncbi.nlm.nih.gov/pubmed/15542594>. Acesso em: 17 nov. 2017.
TEITELBAUM, S. L.; ROSS, F. P. Genetic regulation os osteoclast development and function. Nat Rev Genet, London, UK, v. 4, n. 8, p. 638-649, Aug. 2003. Disponível em: <https://www.ncbi.nlm.nih.gov/pubmed/12897775>. Acesso em: 22 nov. 2017.
TREISTER, N. et al. Dental panoramic radiographic evaluation in bisphosphonate- associated osteonecrosis of the jaws. Oral Dis, Copenhagen, Denmark, v. 15, n. 1, p. 88-92, Jan. 2009. Disponível em:
<https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1601-0825.2008.01494.x>. Acesso em: 30 abr. 2017.
35
WOODFIN, A.; VOISIN, M. B.; NOURSHARGH, S. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol, Baltimore, Md, v. 27, n. 12, p. 2514–2523, Dec. 2007. Disponível em:
<https://www.ncbi.nlm.nih.gov/pubmed/17872453>. Acesso em: 14 nov. 2017.
YASUDA, H. et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to
TRANCE/RANKL. Proc Natl Acad Sci U S A, Washington, DC, v. 95, n. 7, p. 3597-3602, Mar. 1998. Disponível em: <https://www.ncbi.nlm.nih.gov/pubmed/9520411>.
Acesso em: 13 maio 2017.
36 ANEXO A – Parecer do Comitê de Ética em seres humanos
37 ANEXO B – Análise Estatística